Publications

Publications2010


Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial.
Batty GD, Li Q, Czernichow S, Neal B, Zoungas S, Huxley R, Patel A, de Galan BE, Woodward M, Hamet P, Harrap SB, Poulter N, Chalmers J; ADVANCE Collaborative Group.
J Am Coll Cardiol. 2010 Nov 30;56(23):1908-13

Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial.
Ninomiya T, Zoungas S, Neal B, Woodward M, Patel A, Perkovic V, Cass A, Cooper M, Grobbee D, Hamet P, Harrap S, Liu L, Mancia G, Mogensen CE, Poulter N, Rodgers A, Williams B, MacMahon S, Chalmers J; ADVANCE Collaborative Group.
J Hypertens. 2010 Jun;28(6):1141-9.

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
Hackam DG, Khan NA, Hemmelgarn BR, Rabkin SW, Touyz RM, Campbell NR, Padwal R, Campbell TS, Lindsay MP, Hill MD, Quinn RR, Mahon JL, Herman RJ, Schiffrin EL, Ruzicka M, Larochelle P, Feldman RD, Lebel M, Poirier L, Arnold JM, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Burgess ED, Burns KD, Vallée M, Prasad GV, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Tobe SW; Canadian Hypertension Education Program.
Can J Cardiol. 2010 May;26(5):249-58. Review.

The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study.
Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, Pan CY, Zoungas S, Grobbee DE, Neal B, Chalmers J, Woodward M; ADVANCE Collaborative Group.
Diabetologia. 2010 May;53(5):821-31. Epub 2010 Feb 17.

A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome.
Racine N, Hamet P, Sampalis JS, Longo N, Bastien N.
J Hum Hypertens. 2010 Nov;24(11):739-48. Epub 2010 Feb 11.

Decreased NKCC1 activity in erythrocytes from African Americans with hypertension and dyslipidemia.
Orlov SN, Gossard F, Pausova Z, Akimova OA, Tremblay J, Grim CE, Kotchen JM, Kotchen TA, Gaudet D, Cowley AW, Hamet P. Am J Hypertens. 2010 Mar;23(3):321-6. Epub 2009 Dec 31.

2009


The impact of a multidisciplinary information technology-supported program on blood pressure control in primary care.
Rinfret S, Lussier MT, Peirce A, Duhamel F, Cossette S, Lalonde L, Tremblay C, Guertin MC, LeLorier J, Turgeon J, Hamet P; LOYAL Study Investigators. Circ Cardiovasc Qual Outcomes. 2009 May;2(3):170-7. Epub 2009 May 5.

A common variant of the FTO gene is associated with not only increased adiposity but also elevated blood pressure in French Canadians.

Pausova Z, Syme C, Abrahamowicz M, Xiao Y, Leonard GT, Perron M, Richer L, Veillette S, Smith GD, Seda O, Tremblay J, Hamet P, Gaudet D, Paus T. Circ Cardiovasc Genet. 2009 Jun;2(3):260-9. Epub 2009 Mar 31.

Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice.
Beetz N, Harrison MD, Brede M, Zong X, Urbanski MJ, Sietmann A, Kaufling J, Barrot M, Seeliger MW, Vieira-Coelho MA, Hamet P, Gaudet D, Seda O, Tremblay J, Kotchen TA, Kaldunski M, Nüsing R, Szabo B, Jacob HJ, Cowley AW Jr, Biel M, Stoll M, Lohse MJ, Broeckel U, Hein L.
J Clin Invest. 2009 Dec;119(12):3597-3612.

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M, Hamet P, Heller SR, Lisheng L, Macmahon S, Mancia G, Neal B, Pan CY, Patel A, Poulter N, Travert F, Woodward M; ADVANCE Collaborative Group.
Diabetologia. 2009 Nov;52(11):2328-36. Epub 2009 Aug 18.

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, MacMahon S, Marre M, Neal B, Patel A, Woodward M, Chalmers J; ADVANCE Collaborative Group, Cass A, Glasziou P, Harrap S, Lisheng L, Mancia G, Pillai A, Poulter N, Perkovic V, Travert F.
Diabetes Care. 2009 Nov;32(11):2068-74. Epub 2009 Aug 3.

Blood pressure variables and cardiovascular risk: new findings from ADVANCE.
Kengne AP, Czernichow S, Huxley R, Grobbee D, Woodward M, Neal B, Zoungas S, Cooper M, Glasziou P, Hamet P, Harrap SB, Mancia G, Poulter N, Williams B, Chalmers J; ADVANCE Collaborative Group.
Hypertension. 2009 Aug;54(2):399-404. Epub 2009 May 26.

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.
Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J; ADVANCE Collaborative Group.
J Am Soc Nephrol. 2009 Aug;20(8):1813-21. Epub 2009 May 14.

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.
Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, Rabkin SW, Hill MD, Padwal R, Touyz RM, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Moe G, Prasad R, Arnold MO, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, DeChamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Bacon SL, Lindsay P, Gilbert RE, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program.
Can J Cardiol. 2009 May;25(5):287-98. Review.

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.
Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, Woodward M, Cooper M, Harrap S, Hamet P, Poulter N, Lip GY, Patel A; ADVANCE Collaborative Group.
Eur Heart J. 2009 May;30(9):1128-35. Epub 2009 Mar 11.

Lowering blood pressure reduces renal events in type 2 diabetes.

de Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, Neal B, Poulter N, Harrap S, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Glasziou P, Grobbee DE, MacMahon S, Chalmers J; ADVANCE Collaborative Group.
J Am Soc Nephrol. 2009 Apr;20(4):883-92. Epub 2009 Feb 18.

Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma.
Lampron A, Bourdeau I, Oble S, Godbout A, Schürch W, Arjane P, Hamet P, Lacroix A.
J Clin Endocrinol Metab. 2009 Mar;94(3):750-6. Epub 2008 Dec 9.

https://onlinecasinosoffers.com/online-casino-canada/ - canadian online casinos